Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

52.9K
Overview
52.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza.

Influenza and other respiratory viruses·2026
Same author

Thyroid-Joint Crosstalk: A Systematic Review and Meta-Analysis of Thyroid Autoimmunity and Dysfunction in Juvenile Idiopathic Arthritis.

The Journal of clinical endocrinology and metabolism·2026
Same author

Impact of regional heterogeneity of RSV infection prophylaxis on bronchiolitis in Italy.

Italian journal of pediatrics·2026
Same author

Clinical Features and Predictors of Severity in Children Hospitalized With Human Metapneumovirus: A Multicenter Italian Study.

The Pediatric infectious disease journal·2026
Same author

Appropriateness and Abuse of Antipyretics, Anti-Inflammatory Drugs and Antibiotics in Children and Adults.

Antibiotics (Basel, Switzerland)·2026
Same author

Inter-society consensus on the management of acute bloody diarrhea and shiga toxin-producing Escherichia coli infection in the molecular microbiology era.

Italian journal of pediatrics·2026

Related Experiment Video

Updated: Mar 7, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.4K

Rotavirus immunization: Global coverage and local barriers for implementation.

Andrea Lo Vecchio1, Ilaria Liguoro2, Jorge Amil Dias3

  • 1Section of Pediatrics, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

Vaccine
|February 21, 2017
PubMed
Summary
This summary is machine-generated.

Rotavirus immunization coverage remains low globally due to high vaccine costs and limited awareness of rotavirus disease severity. Public health initiatives are crucial to overcome these barriers and increase rotavirus vaccination rates.

Keywords:
DiarrheaImmunizationImplementationRotavirusVaccine

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.6K
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.4K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.6K
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.5K

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Rotavirus (RV) is a leading cause of childhood gastroenteritis and mortality worldwide.
  • Rotavirus immunization (RVI) is a key strategy for diarrheal disease control, identified as a priority by FISPGHAN.
  • A FISPGHAN working group assessed global RVI coverage and implementation barriers.

Purpose of the Study:

  • To estimate current global rotavirus immunization coverage.
  • To identify local barriers hindering the implementation of rotavirus immunization programs.
  • To inform strategies for improving RVI uptake.

Main Methods:

  • A global survey was distributed to national experts in infectious diseases and health authorities.
  • Data collected between March 2015 and April 2016.
  • Information gathered on local RVI recommendations, costs, and perceived barriers.

Main Results:

  • 62% response rate from 79 contacted countries; 55% recommended RVI.
  • 16 countries (33%) introduced RVI into their National Immunization Schedule between 2012-2014.
  • Elevated vaccine cost (49%) is the primary barrier; family payment (43%) and low perceived disease severity (47%) also significantly impede RVI.

Conclusions:

  • Rotavirus immunization implementation remains unacceptably low a decade after introduction.
  • Barriers to RVI vary by region, with cost and awareness being major factors.
  • Public health authorities must enhance caregiver/provider education and collaborate locally to boost RVI.